These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18949334)

  • 21. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
    Roberts M; Bacon A; Li J; Chatfield S
    Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
    Simon R; Tennant SM; Wang JY; Schmidlein PJ; Lees A; Ernst RK; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.
    Li Y; Wang S; Scarpellini G; Gunn B; Xin W; Wanda SY; Roland KL; Curtiss R
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):593-8. PubMed ID: 19114649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a monoclonal antibody directed against Salmonella enterica serovar Typhimurium and serovar [4,5,12:i:-].
    Rementeria A; Vivanco AB; Ramirez A; Hernando FL; Bikandi J; Herrera-León S; Echeita A; Garaizar J
    Appl Environ Microbiol; 2009 Mar; 75(5):1345-54. PubMed ID: 19124586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms.
    De Ridder L; Maes D; Dewulf J; Butaye P; Pasmans F; Boyen F; Haesebrouck F; Van der Stede Y
    Vet J; 2014 Nov; 202(2):303-8. PubMed ID: 25278382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of an immune evasion gene,
    Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
    Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
    DiGiandomenico A; Rao J; Goldberg JB
    Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immunogenicity and protective efficacy of outer membrane vesicles from Salmonella Typhimurium and Salmonella Choleraesuis.
    Tian Y; Huang S; Zhou G; Fei X; Li YA; Li Q; Wang S; Shi H
    Vet Microbiol; 2024 Jul; 294():110131. PubMed ID: 38805917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
    Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
    Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.